These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36251090)

  • 21. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation.
    Wong YC; Holzbaur EL
    J Neurosci; 2014 Jan; 34(4):1293-305. PubMed ID: 24453320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HMG-CoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells.
    Hattori Y; Nakanishi N; Akimoto K; Yoshida M; Kasai K
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):176-82. PubMed ID: 12588756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
    Ban JJ; Chung JY; Lee M; Im W; Kim M
    Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyglutamine-Specific Gold Nanoparticle Complex Alleviates Mutant Huntingtin-Induced Toxicity.
    Wahyuningtyas D; Chen WH; He RY; Huang YA; Tsao CK; He YJ; Yu CY; Lu PC; Chen YC; Wang SH; Ng KC; Po-Wen Chen B; Wei PK; Shie JJ; Kuo CH; Sun YH; Jen-Tse Huang J
    ACS Appl Mater Interfaces; 2021 Dec; 13(51):60894-60906. PubMed ID: 34914364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.
    Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H
    Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal Biochemical Assay Analysis of Mutant Huntingtin Exon 1 Protein in R6/2 Mice.
    Morozko EL; Ochaba J; Hernandez SJ; Lau A; Sanchez I; Orellana I; Kopan L; Crapser J; Duong JH; Overman J; Yeung S; Steffan JS; Reidling J; Thompson LM
    J Huntingtons Dis; 2018; 7(4):321-335. PubMed ID: 30452420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of P-glycoprotein expression in brain capillaries in Huntington's disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone.
    Kao YH; Chern Y; Yang HT; Chen HM; Lin CJ
    J Cereb Blood Flow Metab; 2016 Aug; 36(8):1412-23. PubMed ID: 26661162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells.
    Sugiyama T; Levy BD; Michel T
    J Biol Chem; 2009 May; 284(19):12691-700. PubMed ID: 19286667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
    Dufour BD; McBride JL
    Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shear stress-mediated upregulation of GTP cyclohydrolase/tetrahydrobiopterin pathway ameliorates hypertension-related decline in reendothelialization capacity of endothelial progenitor cells.
    Bai YP; Xiao S; Tang YB; Tan Z; Tang H; Ren Z; Zeng H; Yang Z
    J Hypertens; 2017 Apr; 35(4):784-797. PubMed ID: 28033126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.
    Busch A; Engemann S; Lurz R; Okazawa H; Lehrach H; Wanker EE
    J Biol Chem; 2003 Oct; 278(42):41452-61. PubMed ID: 12888569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart.
    Melkani GC; Trujillo AS; Ramos R; Bodmer R; Bernstein SI; Ocorr K
    PLoS Genet; 2013; 9(12):e1004024. PubMed ID: 24367279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
    Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
    Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelinosome Organelles in the Retina of R6/1 Huntington Disease (HD) Mice: Ubiquitous Distribution and Possible Role in Disease Spreading.
    Yefimova MG; Béré E; Cantereau-Becq A; Meunier-Balandre AC; Merceron B; Burel A; Merienne K; Ravel C; Becq F; Bourmeyster N
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington's disease patients.
    Koyuncu S; Saez I; Lee HJ; Gutierrez-Garcia R; Pokrzywa W; Fatima A; Hoppe T; Vilchez D
    Nat Commun; 2018 Jul; 9(1):2886. PubMed ID: 30038412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation.
    Cai S; Alp NJ; McDonald D; Smith I; Kay J; Canevari L; Heales S; Channon KM
    Cardiovasc Res; 2002 Sep; 55(4):838-49. PubMed ID: 12176133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel GTPCH deficiency mouse model exhibiting tetrahydrobiopterin-related metabolic disturbance and infancy-onset motor impairments.
    Jiang X; Liu H; Shao Y; Peng M; Zhang W; Li D; Li X; Cai Y; Tan T; Lu X; Xu J; Su X; Lin Y; Liu Z; Huang Y; Zeng C; Tang YP; Liu L
    Metabolism; 2019 May; 94():96-104. PubMed ID: 30742839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.